Can hypercalcaemia be avoided during oral calcitriol pulse therapy of secondary hyperparathyroidism in haemodialysis patients?
- PMID: 8559511
Item in Clipboard
Can hypercalcaemia be avoided during oral calcitriol pulse therapy of secondary hyperparathyroidism in haemodialysis patients?
Nephrol Dial Transplant.
1995.
No abstract available
Similar articles
-
[Vitamin D "pulse" therapy for secondary hyperparathyroidism due to long-term hemodialysis in patients with chronic kidney failure].Nihon Rinsho. 1991 Dec;49 Suppl:720-4. Nihon Rinsho. 1991. PMID: 1808342 Japanese. No abstract available.
-
Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism.Clin Nephrol. 1993 Oct;40(4):216-20. Clin Nephrol. 1993. PMID: 8261678 Clinical Trial.
-
Hyperparathyroidism in CAPD patients: therapy with pulse oral calcitriol.Adv Perit Dial. 1993;9:257-9. Adv Perit Dial. 1993. PMID: 8105938
-
[Serum calcium concentration and the safety of vitamin D therapy].Clin Calcium. 2004 Sep;14(9):79-82. Clin Calcium. 2004. PMID: 15577116 Review. Japanese.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
Cited by
-
Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.J Vet Emerg Crit Care (San Antonio). 2013 Mar-Apr;23(2):134-62. doi: 10.1111/vec.12036. J Vet Emerg Crit Care (San Antonio). 2013. PMID: 23566108 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical